Sartorius supports development of coronavirus vaccine
Sartorius supports the development of the first vaccine candidate against the novel coronavirus to enter clinical trials
Sartorius supports the development of the first vaccine candidate against the novel coronavirus to enter clinical trials
AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19
Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic
The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.
The panel covers entire genome of the new coronavirus to facilitate complete genome sequencing and support epidemiological studies
The company seeks quick clearance of the test through an FDA emergency use authorization
Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic
The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA
Researchers from the University of Oxford, UK, are developing rapid testing technology for COVID-19
The test kit aims to differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes
IDT's primer and probe kit can be used as a component of the CDC testing protocol for the diagnosis and detection of COVID-19
Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020
Join this webinar to explore the biological and technical considerations when developing, testing, optimizing, and validating multiplex panels
The new products are said to offer increased flexibility and efficiency for low- to high-volume molecular testing laboratories
The new tubes and racks promise long-term stability and uninterrupted operation in biobanking and compound storage applications
These CAR-T cell therapies are designed to be used in the treatment of hematological malignancies
Panel includes atypical pathogens and is expected to substantially increase total addressable market for the Unyvero system in the U.S.
Joint venture to develop next generation cell and gene therapies incorporating Affimer proteins
Meet the inflammation and immunity researcher studying the fundamental cellular mechanisms behind uncontrolled inflammatory responses to allergens
Researchers at Queen’s University, Canada, explain how their new core facility and its cutting-edge flow cytometry and cell sorting technology are accelerating cardiopulmonary research
A population genetics scientist tells SelectScience how she’s combating red mite infestations on chicken farms
Ferris El-tayyeb discusses the challenges of animal oncology, the lab equipment helping to accelerate progress towards personalized immunotherapies, and his hopes for the future
Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies